Drug Screening | Environmental XPRT
Articles & Whitepapers
-
Exploring the Revolution of PDO-based Drug Screening in Personalized Medicine
In the current age of medical advances, Personalized Medicine is the frontline of healthcare advancement. This is largely due to the ability of medical professionals to tailor healthcare — with medical decisions, practices, and/or products being customized to an individual patient. Holding on to this trend of providing highly personalized treatment to patients, Patient-derived Organoid ...
-
Primary Cell Isolation and Culture
With extensive experience in isolating and culturing primary cells from various tissues and organs, Creative Bioarray can provide a wide range of primary cells to be used as more biologically ...
News
-
Kadimastem Awarded Patent in Japan for AstroRx® For ALS and Drug Screening
Kadimastem Ltd. (TASE: KDST), a clinical stage cell therapy company developing a treatment for ALS, exploring one for multiple sclerosis and developing a potential cure for diabetes, has received a patent from the Japan Patent Office for ...
Advancing Laboratory Efficiency: Alfa Chemistry Launches Automated Chemical Synthesis Solutions
CD Bioparticles Launches 3D Cell Culture Substrate for Bio-research
CD ComputaBio Introduces First Principle Calculations for Revolutionizing Computational Chemistry and Empowering Biotech Research
MDCK Permeability Assay Now Available at Profacgen
Equipment & Solutions
-
Showcase
FT-NIR Spectrometer for Solids Analysis
The QuasIR 3000 FT-NIR spectrometer was designed from the ground up to offer the industry a new kind of NIR analysis solution – a solution that brings together the portability required to move NIR analysis closer to point-of-need, combined with unmatched spectroscopic performance for the fastest and most accurate results.
